A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer

INTRODUCTION: Current treatment options for advanced esophagogastric cancer (AEGC) are still unsatisfactory. The aim of this prospective phase Ib/II study was to evaluate the safety and efficacy of a novel regimen, AVDCX, consisting of weekly docetaxel and cisplatin together with capecitabine and be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Brenner, Baruch, Sarfaty, Michal, Purim, Ofer, Kundel, Yulia, Amit, Limor, Abramovich, Amir, Sadeh Gonik, Udi, Idelevich, Efraim, Gordon, Noa, Medalia, Gal, Sulkes, Aaron
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938513/
https://ncbi.nlm.nih.gov/pubmed/27390847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0157548
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars